Cutaneous graft-versus-host disease

被引:134
作者
Aractingi, S [1 ]
Chosidow, O
机构
[1] Hop Tenon, Dept Dermatol, F-75970 Paris, France
[2] Hop La Pitie Salpetriere, Dept Internal Med, Paris, France
关键词
D O I
10.1001/archderm.134.5.602
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Graft-versus-host disease (GVHD) includes inflammatory and/or fibrosing manifestations that may arise at various times after transplantation of any organ containing lymphoid cells. For the dermatologist, the importance of GvHD is real and current. Indeed, because it has become easier to perform bone marrow transplantation (BMT), the indications of BMT have become broader, making follow-up of patients receiving grafts a widespread practice. Nonetheless, GvHD remains a frequent complication of BMT and its principal target organ is the skin. Furthermore, recent innovations, such as grafting of umbilical cord blood and the mobilization of peripheral blood progenitor cells, will be the source of new questions concerning the development of GvHD under these conditions. Finally, because of its analogies with other spontaneous idiopathic skin diseases, GVHD constitutes a model that may lead to a better understanding of the pathophysiological features of these diseases. In this review, the cutaneous aspects of GVHD are emphasized.
引用
收藏
页码:602 / 612
页数:11
相关论文
共 75 条
[41]   Apoptosis is the mode of keratinocyte death in cutaneous graft-versus-host disease [J].
Langley, RGB ;
Walsh, N ;
Nevill, T ;
Thomas, L ;
Rowden, G .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (02) :187-190
[42]   IMMUNOHISTOLOGY OF SKIN AND RECTUM BIOPSIES IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
LESKINEN, R ;
TASKINEN, E ;
VOLIN, L ;
RUUTU, T ;
HAYRY, P .
APMIS, 1992, 100 (12) :1115-1122
[43]   A PROSPECTIVE-STUDY OF THE HISTOLOGICAL-CHANGES IN THE SKIN IN PATIENTS RECEIVING BONE-MARROW TRANSPLANTS [J].
LEVER, R ;
TURBITT, M ;
MACKIE, R ;
HANN, I ;
GIBSON, B ;
BURNETT, A ;
WILLOUGHBY, M .
BRITISH JOURNAL OF DERMATOLOGY, 1986, 114 (02) :161-170
[44]   SECONDARY MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION IN ADULTS [J].
LOWSKY, R ;
LIPTON, J ;
FYLES, G ;
MINDEN, M ;
MEHARCHAND, J ;
TEJPAR, I ;
ATKINS, H ;
SUTCLIFFE, S ;
MESSNER, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) :2187-2192
[45]  
MCCARTHY PL, 1991, BLOOD, V78, P1915
[46]  
MURPHY GF, 1991, AM J PATHOL, V138, P983
[47]   ICAM-1 EXPRESSION ON EPIDERMAL-KERATINOCYTES IN CUTANEOUS GRAFT-VERSUS-HOST DISEASE [J].
NORTON, J ;
SLOANE, JP .
TRANSPLANTATION, 1991, 51 (06) :1203-1206
[48]   LYMPHOCYTE-T SUBSETS IN THE LESIONAL SKIN OF ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANT PATIENTS [J].
PALLER, AS ;
NELSON, A ;
STEFFEN, L ;
GOTTSCHALK, L ;
KAIZER, H .
ARCHIVES OF DERMATOLOGY, 1988, 124 (12) :1795-1801
[49]   THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE [J].
PARKER, PM ;
CHAO, N ;
NADEMANEE, A ;
ODONNELL, MR ;
SCHMIDT, GM ;
SNYDER, DS ;
STEIN, AS ;
SMITH, EP ;
MOLINA, A ;
STEPAN, DE ;
KASHYAP, A ;
PLANAS, I ;
SPIELBERGER, R ;
SOMLO, G ;
MARGOLIN, K ;
ZWINGENBERGER, K ;
WILSMAN, K ;
NEGRIN, RS ;
LONG, GD ;
NILAND, JC ;
BLUME, KG ;
FORMAN, SJ .
BLOOD, 1995, 86 (09) :3604-3609
[50]  
PARKMAN R, 1986, J IMMUNOL, V136, P3543